GleamWall
中文EN

ALC ALCON INC IFRS

Ophthalmic Goods · NYSE · SEC CIK 1167379 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY4.9%
TTM net income YoY-3.7%
TTM EPS YoY-3.4%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR43.0%

Margins

Gross margin55.2%
Operating margin13.1%
Net margin9.4%
FCF margin16.6%
EBITDA margin—

Returns

ROE4.5%
ROA3.2%
ROIC (approx.)4.6%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets30.2%
Debt / equity0.21x
Current ratio2.12x
Interest coverage6.67x

Cash quality & payout

Operating cash flow / net income2.32x
Accruals ratio-4.2%
Payout ratio16.9%
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$10.40B$9.91B
Cost of revenue$4.59B$4.33B
Gross profit$5.75B$5.51B
R&D expense$990.00M$876.00M
SG&A expense$3.45B$3.25B
Operating income$1.36B$1.41B
Interest expense$204.00M$192.00M
Pretax income$1.16B$1.26B
Income tax$180.00M$238.00M
Net income$980.00M$1.02B
EPS (basic)1.992.06
EPS (diluted)1.982.05
Weighted avg. shares (diluted)496.20M497.50M
Balance sheet
Cash & equivalents$1.53B$1.68B
Short-term investments$80.00M$153.00M
Receivables$1.94B$1.74B
Inventory$2.39B$2.27B
Current assets$6.45B$6.31B
PP&E, netmay include right-of-use assets (IFRS)$4.77B$4.39B
Goodwill$9.26B$8.95B
Intangibles$9.01B$8.59B
Total assets$31.55B$30.35B
Current liabilities$3.05B$2.28B
Short-term debt$575.00M$105.00M
Long-term debt$4.16B$4.54B
Total debt$4.74B$4.64B
Total liabilities$9.52B$8.79B
Shareholders' equity$22.03B$21.55B
Net debt$3.21B$2.97B
Cash flow statement
Operating cash flow$2.27B$2.08B
Capital expenditure$543.00M$473.00M
Free cash flow$1.73B$1.60B
Investing cash flow-$1.34B-$1.17B
Financing cash flow-$1.12B-$322.00M
Stock-based compensation$171.00M$162.00M
Dividends paid$166.00M$130.00M
Share buybacks$676.00M$0

Free plan shows the latest 2 periods; Pro shows all 13 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.